Biomarkers to determine an early erosive process in RA

​The UPEDRA study (Prediction of erosive disease in early RA by ultrasound and cartilage biodegradation markers) is a collaboration between the Universities of Zurich and Basel. Newly diagnosed RA-patients are examined clinically as well as with x-ray, ultrasound and MRI at the beginning and during the progress of their treatment. This study takes place in close collaboration with the Clinical Trials Center RUZ.